Esperion to Report First Quarter 2024 Financial Results on May 7

Esperion (NASDAQ: ESPR) today announced it will report first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.

GlobeNewswireApr 23 20:00

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37

Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Friday. Shares of Applied Digital Corporation (NASDAQ:APLD) fell sharply in today's pre-market trading after

BenzingaApr 12 20:04

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday's session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9

BenzingaApr 12 01:33

Needham: Reiterated the Esperion Therapeutics (ESPR.US) rating, adjusted from buy to buy rating, target price $8.00.

Needham: Reiterated the Esperion Therapeutics (ESPR.US) rating, adjusted from buy to buy rating, target price $8.00.

Zhitong FinanceApr 10 18:50

Esperion Therapeutics Shares Are Trading Lower. The Company Announced the Presentation of New Data From CLEAR Outcomes.

Esperion Therapeutics Shares Are Trading Lower. The Company Announced the Presentation of New Data From CLEAR Outcomes.

BenzingaApr 9 02:20